In an order posted to the site of the U.S. District Court for the District of Delaware, the court stated: “10x Genomics (TXG), Inc. and Prognosys Biosciences, Inc. sued NanoString Technologies, Inc.1 ...

10X Genomics (NASDAQ:TXG) won a permanent injunction against NanoString Technologies in a patent dispute. 10X Genomics rose 3.3%. A permanent injunction will be issued on Jan. 10, U.S. District Judge ...

PLEASANTON, Calif., Dec. 23, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it had secured a permanent injunction in the U.S.

* NANOSTRING TECHNOLOGIES-TO USE ABOUT $89.0 MILLION OF NET PROCEEDS TO PREPAY AMOUNTS BORROWED, FEES OWING RELATED TO TERMINATION OF SENIOR TERM LOAN FACILITY * NANOSTRING-TO USE ABOUT $89.0 MILLION ...

UPC Denies Second Preliminary Injunction Request; Prior Injunctions Against NanoString's CosMx Products in Europe Remain in Full Effect Eric S. Whitaker, Chief Legal Officer for 10x Genomics, said, ...

* Nanostring technologies-‍under terms of deal, lam will provide up to $50 million of funding intended to cover costs of development and regulatory approval * Nanostring technologies inc - ‍lam will ...

Seattle's NanoString Technologies ($NSTG) stands to make up to $45 million if it can come up with a successful companion diagnostic test to screen for a subset of ...

A company with roots in developing tools for translational research has raised $15.3 million to execute the first step of its pursuit of market share in diagnostics. When it was granted the CE Mark in ...

A top European court ruled against Harvard last week in a patent dispute against biotech company NanoString Technologies, invalidating one of the University’s two disputed patents in three European ...